Gregory Miller

Gregory Miller is an accomplished executive in the biotechnology sector, currently serving as the Chief Business Officer at FogPharma and previously holding the position of Chief Executive Officer at Transition Bio, Inc. Miller has extensive experience in business leadership roles, including Chief Business Officer at Atalanta Therapeutics and Visterra Inc., as well as Vice President of Business & Corporate Development at Concert Pharmaceuticals. Educational credentials include an MBA in General Management from the Questrom School of Business at Boston University and an undergraduate degree from Brandeis University.